Clinical trial
Clinical Trial Opportunities in India Report
A joint report titled “Clinical Trial Opportunities in India” Report was released recently by the PwC India and US-India Chamber of Commerce (USAIC). Key findings of the Report: Clinical trial activity in India was historically low until 2014 due to ..
Month: Current Affairs - May, 2023
Category: Reports & Indexes Current Affairs
Lecanemab Approved for Alzheimer’s Treatment
The US Food and Drug Administration (FDA) has approved lecanemab, a monoclonal antibody developed by Eisai and Biogen, for the treatment of Alzheimer’s disease. Lecanemab is the second drug to receive approval for the treatment of Alzheimer’s and the first ..
Month: Current Affairs - January, 2023
Category: Science & Technology Current Affairs
Bharat Biotech Nasal Booster Trials
The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are being introduced for the vulnerable population. The booster doses will provide the ..
Month: Current Affairs - January, 2022
Category: Economy & Banking Current Affairs • Science & Technology Current Affairs
COVAXIN to use Alhydroxiquim-II to boost Immune Response
The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has sought the approval of Drugs Controller General of India to begin phase ..
Month: Current Affairs - October, 2020
ICMR to launch COVAXIN on August 15
On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes that are conducting the clinical trials of the indigenous vaccine. Currently India ..
Month: Current Affairs - July, 2020
Centre issued new Drugs and Clinical Trials Rules, 2019
Health and Family Welfare Ministry have issued the Drugs and Clinical Trials Rules, 2019 with a motive to enhance clinical research in the country. The new rules will alter the regulatory landscape for the approval of new drugs and conduct ..
Maharashtra registered Maximum Number of Deaths due to SAEs during Drug Trials
As per the data of the Drug Controller-General of India, India recorded 2061 drug trial-related deaths during the period (January 2008- January 2012). Maharashtra registered maximum number of 268 deaths due to SAEs (Serious Adverse Events) during drug trials while ..
Month: Current Affairs - August, 2012
Regulatory Mechanism for Biodiversity sector soon
A regulatory mechanism in Biodiversity sector to be in place following the recommendations Objective: To safeguard public health and protect environment. Quality Control lab in Delhi has been asked to bring wider range of bio-technology products under its ambit to ..